Eir Partners (Eir), a middle market private equity firm focused on healthcare technology and tech-enabled services, announces the majority recapitalization of PharmaForceIQ, an AI-driven, precision omnichannel orchestration and measurement solution to pharmaceutical and life science companies. Headquartered in Boston and Orlando, PFIQ has distinguished itself as the fastest growing independent provider of omnichannel marketing solutions for pharmaceutical brands. PFIQ is the only software platform in the market that offers real-time omnichannel deployments and measurement in the moments that matter most across commercial, medical and market access teams.
Read the full article: Eir Partners Announces Majority Growth Investment in PharmaForceIQ //
Source: https://www.prnewswire.com/news-releases/eir-partners-announces-majority-growth-investment-in-pharmaforceiq-302243538.html